About Abortion Are You Pregnant? Professional Education Publications and Research U.S. Public Policy In Canada Membership Support NAF About NAF
 Find a Provider | News | Blog | Get Involved | Action Alerts | Clinicians for Choice | En español | En français | Site Map | Contact Us | NAF Home
NAF logo publications and research from NAF and our members provide data and evidence-based resources on all aspects of abortion care and delivery
Publications and ResearchResearch
> Guttmacher Institute
> Gynuity Health Projects
Resources and Links
Usage Policy
Search prochoice.org
Powered by
NAF Hotline
Find a provider:

(no funding assistance provided on this line)


NOTE: Links to other websites open a new browser window; close that window to return to this page.

Gynuity Health Projects is a research and technical assistance organization dedicated to the idea that all people should have access to the fruits of medical science and technology development.

Gynuity works globally with a particular emphasis on resource-poor environments and underserved populations. Gynuity conducts research on the use of existing technologies; develops and introduces new technologies; disseminates scientific information to policymakers, reproductive health professionals, and the public; and generates data for regulatory filings while working with regulatory agencies.

Gynuity Health Projects recently joined with the Reproductive Health Technologies Project to convene expert meetings evaluating the use of misoprostol for abortion induction and for the treatment of incomplete abortion and miscarriage. Professionals with epidemiological, clinical and programmatic expertise reached consensus on the appropriate use of misoprostol based on the best current information. The results can be found in a series of documents called "Instructions for Use."

Please Note: The National Abortion Federation's Clinical Policies Board Committee has reviewed the "Consensus Statement: Instructions for use - Abortion Induction with Misoprostol (Cytotec®) in Pregnancies up to 9 Weeks LMP" produced by Gynuity Health Project and Reproductive Health Technologies Project. The misoprostol-only regimens described in this document are effective for medical abortion up to 9 weeks LMP, though mifepristone/misoprostol regimens are 5-10% more effective and seem to have significantly fewer gastrointestinal side effects.

photo of doctors
links and resources: Many educational and activist tools have been developed about abortion. Learn more.
Order publications: Order any of NAF's publications and resources online today.
Clinical and professional publications: Find evidence-based educational tools for health care providers and medical educators
NAF website Copyright 2010 National Abortion Federation. Use of this site signifies your agreement to our Usage and Privacy Policy.